OGN - Organon & Co. Stock Price and Quote

OGN [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	6.23	EPS (ttm)	3.59	Insider Own	0.06%	Shs Outstand	254.37M	Perf Week	0.58%
Market Cap	5.71B	Forward P/E	4.74	EPS next Y	4.72	Insider Trans	0.00%	Shs Float	254.22M	Perf Month	-9.97%
Income	917.00M	PEG	-	EPS next Q	1.12	Inst Own	78.60%	Short Float / Ratio	2.86% / 3.37	Perf Quarter	-20.83%
Sales	6.17B	P/S	0.92	EPS this Y	-32.40%	Inst Trans	-0.05%	Short Interest	7.28M	Perf Half Y	-21.74%
Book/sh	-3.51	P/B	-	EPS next Y	8.15%	ROA	8.60%	Target Price	32.89	Perf Year	-34.80%
Cash/sh	2.77	P/C	8.09	EPS next 5Y	-2.00%	ROE	-84.40%	52W Range	21.11 - 39.09	Perf YTD	-19.84%
Dividend	1.12	P/FCF	15.35	EPS past 5Y	-12.80%	ROI	11.40%	52W High	-42.72%	Beta	-
Dividend %	5.00%	Quick Ratio	1.20	Sales past 5Y	-10.10%	Gross Margin	63.00%	52W Low	6.06%	ATR	0.79
Employees	10000	Current Ratio	1.60	Sales Q/Q	-7.40%	Oper. Margin	18.20%	RSI (14)	31.80	Volatility	3.03% 3.29%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-46.70%	Profit Margin	14.90%	Rel Volume	1.05	Prev Close	21.67
Shortable	Yes	LT Debt/Eq	-	Earnings	Feb 16 BMO	Payout	31.00%	Avg Volume	2.16M	Price	22.39
Recom	2.60	SMA20	-6.96%	SMA50	-19.13%	SMA200	-21.77%	Volume	2,262,917	Change	3.32%

Mar-16-23

Initiated

Raymond James

Outperform

$33

Oct-14-22

Downgrade

BofA Securities

Neutral → Underperform

$27 → $25

Sep-06-22

Upgrade

Piper Sandler

Neutral → Overweight

$37 → $34

Aug-05-22

Downgrade

BofA Securities

Buy → Neutral

$40 → $37

Apr-27-22

Initiated

Goldman

Buy

$40

Apr-06-22

Resumed

Morgan Stanley

Equal-Weight

$35

Oct-07-21

Initiated

Piper Sandler

Neutral

$35

Sep-01-21

Initiated

BofA Securities

Buy

$43

Jul-22-21

Initiated

Citigroup

Buy

$35

Jun-15-21

Initiated

JP Morgan

Neutral

$38

Show Previous Ratings

Mar-07-23 07:00AM	Organon Launches "Her Plan is Her Power," a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist Business Wire
Mar-03-23 07:30AM	Organon Canada receives the Women in Governance (WiG) Parity Certification SME, further demonstrating its commitment to gender parity in the workplace CNW Group
Feb-27-23 07:30AM	Ahead of International Women's Day, Organon Canada Spotlights the Importance of Supporting Women's Equity While Highlighting the Cost of Not Investing in Their Health CNW Group
Feb-16-23 07:30AM	Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022 Business Wire -15.00%
Feb-13-23 06:43AM	Ahead of International Women's Day, Organon Calls for Recognition of the Impacts of Underinvesting in Women's Health PR Newswire
07:30AM	Loading…
Feb-06-23 07:30AM	Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023 Business Wire
Jan-27-23 12:10PM	Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report? Zacks
Jan-05-23 07:30AM	Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy Business Wire
Dec-15-22 07:30AM	Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference Business Wire
Dec-12-22 08:00AM	Daré Bioscience Announces New Development Program, DARE-PDM1, as a Potential First-in-Category Treatment for Primary Dysmenorrhea GlobeNewswire
07:30AM	Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary Business Wire
Nov-15-22 07:30AM	Organon To Present at the Piper Sandler 34th Annual Healthcare Conference Business Wire
Nov-14-22 07:40AM	Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World ACCESSWIRE
07:30AM	Organon Canada launches Ontruzant®, a biosimilar of the reference biologic Herceptin®, providing patients in Canada with certain breast and gastric cancers with an additional therapeutic option at a lower cost CNW Group
Nov-07-22 07:30AM	Organon Canada launches Aybintio®, a biosimilar of the reference biologic Avastin®, providing a new option at a reduced cost for Canadians living with certain aggressive forms of cancer CNW Group
07:30AM	Loading…
Nov-03-22 07:30AM	Organon Reports Results for the Third Quarter Ended September 30, 2022 Business Wire
Oct-20-22 07:30AM	Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022 Business Wire
Sep-26-22 07:00AM	Organon Canada reinforces the need to raise awareness and access for contraception methods with nearly half of pregnancies unplanned CNW Group
Aug-17-22 07:30AM	Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA (adalimumab-bwwd) Business Wire
Aug-07-22 08:29AM	Organon (NYSE:OGN) Is Paying Out A Dividend Of $0.28 Simply Wall St.
Aug-04-22 07:30AM	Organon Reports Results for the Second Quarter Ended June 30, 2022 Business Wire
Jul-28-22 07:30AM	Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate Business Wire
Jul-25-22 10:24AM	What Kind Of Shareholders Hold The Majority In Organon & Co.'s (NYSE:OGN) Shares? Simply Wall St.
Jul-21-22 07:30AM	Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022 Business Wire
06:30AM	Cognizant Teams Up with Organon to Speed Delivery of Pharmaceutical Products and Improve Women's Healthcare PR Newswire
Jun-30-22 08:00AM	Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis GlobeNewswire
Jun-13-22 08:30AM	Organon Enters into Global License Agreement to Commercialize Henlius Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates Business Wire
Jun-09-22 11:34AM	Those who invested in Organon (NYSE:OGN) a year ago are up 37% Simply Wall St.
Jun-02-22 07:31AM	On One Year Anniversary, Organon Introduces Global Environmental, Social and Governance (ESG) Strategy and Commitments with Publication of Inaugural ESG Report CNW Group
07:00AM	On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report Business Wire
10:45AM	Loading…
May-10-22 10:45AM	With stock up 8.2%, Insiders of Organon & Co. (NYSE:OGN) must be wishing they had bought more last year Simply Wall St.
May-05-22 07:30AM	Organon Reports Results for the First Quarter Ended March 31, 2022 Business Wire +5.06%
Apr-21-22 07:30AM	Organon To Report First Quarter Results and Host Conference Call on May 5, 2022 Business Wire
Apr-13-22 06:30AM	WeWork Wants to Be a Tech Company Again, Sort Of Bloomberg
Apr-05-22 01:07PM	Merck: An Undervalued Stock With a Safe Yield GuruFocus.com
Mar-31-22 07:00AM	Organon Enters into Global License Agreement to Commercialize Daré Biosciences XACIATO (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV) Business Wire
Mar-29-22 07:00AM	Orogen Appoints Mr. Justin Quigley as Board Chair ACCESSWIRE
Mar-19-22 08:55AM	Insider Buying: The Orogen Royalties Inc. (CVE:OGN) Independent Director Just Bought 1,500% More Shares Simply Wall St.
Mar-17-22 10:45AM	Top Pharmaceutical Stocks for Q2 2022 Investopedia
Mar-02-22 07:00AM	Organon To Present at the Cowen 42nd Annual Healthcare Virtual Conference Business Wire +5.07%
Mar-01-22 06:55AM	Meghan Rivera Appointed US Managing Director, Organon Business Wire
Feb-20-22 07:20AM	Organon & Co. (NYSE:OGN) Looks Interesting, And It's About To Pay A Dividend Simply Wall St.
Feb-17-22 06:30AM	Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021 Business Wire
Feb-16-22 08:30AM	Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the Peoples Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam Business Wire
Feb-15-22 01:56PM	How Many Organon & Co. (NYSE:OGN) Shares Do Institutions Own? Simply Wall St.
Feb-08-22 09:38AM	Hikari Tsushin, Inc. Buys Lockheed Martin Corp, Altria Group Inc, Phillips 66, Sells Wells ... GuruFocus.com
Feb-07-22 06:38PM	Opus Investment Management Inc Buys BTC iShares Core MSCI EAFE ETF, iShares Core MSCI ... GuruFocus.com
06:38PM	Terril Brothers, Inc. Buys SPDR Bloomberg Investment Grade Floating Rate ETF, AT&T Inc, ... GuruFocus.com
05:38PM	Ar Asset Management Inc Buys Organon, Prometheus Biosciences Inc, Prometheus Biosciences Inc, ... GuruFocus.com
09:38AM	Parthenon Llc Buys Eaton Corp PLC, Salesforce. ... GuruFocus.com
Feb-04-22 05:38PM	Kentucky Retirement Systems Insurance Trust Fund Buys EPAM Systems Inc, Signature Bank, FactSet ... GuruFocus.com
05:38PM	Sound Shore Management Inc Buys PACCAR Inc, Organon, Pfizer Inc, Sells Fiserv Inc, Comcast ... GuruFocus.com
01:38PM	Brooks, Moore & Associates, Inc. Buys JPMorgan Ultra-Short Income ETF, Webster Financial ... GuruFocus.com
Feb-03-22 01:38PM	First National Trust Co Buys Caterpillar Inc, ViacomCBS Inc, Boston Scientific Corp, Sells ... GuruFocus.com
09:38AM	Schnieders Capital Management Llc Buys PagerDuty Inc, 3M Co, iShares TIPS Bond ETF, Sells ... GuruFocus.com
Feb-02-22 09:38AM	Asahi Life Asset Management Co., Ltd. Buys Organon, Applied Materials Inc, TJX Inc, Sells Bank ... GuruFocus.com
08:00AM	Organon Canada Declares Paid Time Off for All Employees on International Women's Day; All Employees in Canada to Focus on Their Own Health in Recognition of Growing Women's Health Inequity CNW Group
07:00AM	Organon Declares Paid Time Off for All Employees on International Womens Day; Employees to Focus on Their Own Health in Recognition of Growing Womens Health Inequity Business Wire
Feb-01-22 07:30AM	Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022 Business Wire
03:21AM	Top Healthcare Stocks for February 2022 Investopedia
Jan-31-22 09:38PM	Accredited Investors Inc. Buys iShares MSCI EAFE ETF, iShares Russell Mid-Cap Growth ETF, ... GuruFocus.com
01:38PM	Bourgeon Capital Management Llc Buys PayPal Holdings Inc, The Walt Disney Co, Organon, Sells ... GuruFocus.com
Jan-28-22 05:38PM	Heritage Investors Management Corp Buys PayPal Holdings Inc, RingCentral Inc, ServiceNow Inc, ... GuruFocus.com
01:38PM	Marathon Asset Mgmt Ltd Buys Microsoft Corp, Thermo Fisher Scientific Inc, Mastercard Inc, ... GuruFocus.com
09:38AM	MU Investments Co., Ltd. Buys Parker Hannifin Corp, Nucor Corp, Best Buy Co Inc, Sells General ... GuruFocus.com
Jan-27-22 09:38AM	Shufro Rose & Co Llc Buys Distillate U.S. ... GuruFocus.com
Jan-26-22 05:38PM	Patten & Patten Inc Buys JPMorgan Equity Premium Income ETF, Delta Air Lines Inc, Lincoln ... GuruFocus.com
Jan-21-22 01:38PM	tru Independence LLC Buys Maxeon Solar Technologies, Cleveland-Cliffs Inc, Verizon ... GuruFocus.com
Jan-19-22 01:38PM	Sippican Capital Advisors Buys Coterra Energy Inc, DaVita Inc, Physicians Realty Trust, Sells ... GuruFocus.com
09:38AM	Welch & Forbes Llc Buys Vanguard Ultra-Short Bond ETF, First Trust Enhanced Short Maturity ... GuruFocus.com
Jan-18-22 05:38PM	Courier Capital Llc Buys SPDR Bloomberg Investment Grade Floating Rate ETF, SPDR Blackstone ... GuruFocus.com
09:38AM	Abacus Planning Group, Inc. Buys Distillate U.S. ... GuruFocus.com
Jan-13-22 05:38PM	Bonness Enterprises Inc Buys Organon, Verizon Communications Inc, Viatris Inc GuruFocus.com
Jan-11-22 07:00AM	NEXPLANON® (ETONOGESTREL EXTENDED-RELEASE SUBDERMAL IMPLANT) NOW COVERED BY ONTARIO, BRITISH COLUMBIA AND NOVA SCOTIA'S PUBLIC FORMULARIES CNW Group
Jan-10-22 01:38PM	Poehling Capital Management, LLC Buys ViacomCBS Inc, Fidelity National Information Services ... GuruFocus.com
01:38PM	Beese Fulmer Investment Management, Inc. Buys PIMCO Enhanced Short Maturity Active ... GuruFocus.com
Jan-07-22 01:38PM	Woodstock Corp Buys Amgen Inc, Applied Materials Inc, FedEx Corp, Sells Reata Pharmaceuticals ... GuruFocus.com
Jan-05-22 01:38PM	Neville Rodie & Shaw Inc Buys Cleveland-Cliffs Inc, Palo Alto Networks Inc, Novo Nordisk ... GuruFocus.com
06:30AM	FDA Accepts Samsung Bioepis and Organons sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate Business Wire
Jan-03-22 09:38PM	Cacti Asset Management Llc Buys Eli Lilly and Co, Organon, General Electric Co, Sells Gates ... GuruFocus.com
Dec-26-21 04:38AM	Tri-Continental Corporation Buys Capital One Financial Corp, Starbucks Corp, AutoZone Inc, ... GuruFocus.com
Dec-20-21 05:38PM	Birmingham Capital Management Co Inc Buys Phillips 66, Organon GuruFocus.com
07:30AM	Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference Business Wire
Dec-18-21 11:38PM	Mfs Variable Insurance Trust Buys JPMorgan Chase, Morgan Stanley, NICE, Sells Bank of America ... GuruFocus.com
08:38PM	Pioneer VCT Mid Cap Value Fund Buys Syneos Health Inc, Pioneer Natural Resources Co, Organon, ... GuruFocus.com
08:38PM	Pioneer VCT Equity Income Fund Buys JPMorgan Chase, Exxon Mobil Corp, Schlumberger, Sells KLA ... GuruFocus.com
Dec-17-21 10:38AM	ASYMmetric ETFs Trust Buys Coterra Energy Inc, Baxter International Inc, Newmont Corp, Sells ... GuruFocus.com
Dec-13-21 11:38PM	Glenview Capital Management Buys Willis Towers Watson PLC, Uber Technologies Inc, Baxter ... GuruFocus.com
09:00AM	Organon Completes Acquisition of Forendo Pharma Business Wire
Dec-11-21 02:38AM	Sterling Capital Funds Buys Booz Allen Hamilton Holding Corp, Coterra Energy Inc, Sells Dick's ... GuruFocus.com
Dec-09-21 01:38PM	Mundoval Funds Buys Lockheed Martin Corp, Organon, Tyson Foods Inc, Sells Citigroup Inc GuruFocus.com
Nov-11-21 06:31AM	Organon Reports Results for the Third Quarter Ended September 30, 2021 Business Wire -5.21%
06:30AM	Organon to Acquire Forendo Pharma Business Wire
Nov-08-21 02:04PM	NEXPLANON® (etonogestrel extended-release subdermal implant) Now Covered by Quebec's Public Formulary CNW Group
Oct-28-21 07:30AM	Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021 Business Wire
Oct-15-21 06:50AM	Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women Business Wire
Oct-11-21 07:30AM	Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage Business Wire
Sep-22-21 06:00AM	Organon wants to help women take control of their birth control CNW Group
Sep-21-21 12:01AM	Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy Business Wire
Sep-01-21 08:15AM	Organon To Present at Morgan Stanleys 19th Annual Global Healthcare Virtual Conference Business Wire

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DiMarco Kathryn	Corporate Controller	Feb 09	Option Exercise	0.00	1,869	0	4,615	Feb 10 06:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience